Canada markets closed

Estrella Immunopharma, Inc. (ESLA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.0150-0.0150 (-1.46%)
At close: 04:00PM EDT
0.9900 -0.03 (-2.46%)
After hours: 07:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 37.16M
Enterprise Value 15.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.37
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-90.71%
S&P500 52-Week Change 326.49%
52 Week High 333.0000
52 Week Low 30.8600
50-Day Moving Average 31.0950
200-Day Moving Average 33.0155

Share Statistics

Avg Vol (3 month) 328.44k
Avg Vol (10 day) 310.34k
Shares Outstanding 536.61M
Implied Shares Outstanding 636.61M
Float 810.53M
% Held by Insiders 171.03%
% Held by Institutions 10.38%
Shares Short (Apr 30, 2024) 44.55k
Short Ratio (Apr 30, 2024) 40.73
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.03%
Shares Short (prior month Mar 28, 2024) 47.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-64.90%
Return on Equity (ttm)-278.12%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.09M
Diluted EPS (ttm)-0.2700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.73M
Total Cash Per Share (mrq)0.13
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)62.34
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-15.82M
Levered Free Cash Flow (ttm)-14.14M